BioXcel Therapeutics, Inc. Recorded Big Gain
Mon, Mar 03, 2025 at 07:32 PM
BioXcel Therapeutics, Inc. (BTAI:NASDAQ) soared at $3.75, representing a gain of 73.6%. On Mon, Mar 03, 2025, BTAI:NASDAQ hit a New 2-Week High of $3.75. The stock got featured on our News Catalysts scanner on Mon, Mar 03, 2025 at 08:16 AM in the 'BIOTECH' category. From Tue, Feb 18, 2025, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Mon, Mar 03, 2025 at $6.81 with a volume of 146M+.
About BioXcel Therapeutics, Inc. (BTAI:NASDAQ)
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Top 10 Gainers:
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 176.92%
- Aclarion Inc. (ACON:NASDAQ), 126.87%
- China Xiangtai Food Co. Ltd. (BTOG:NASDAQ), 75.34%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 73.61%
- ClearOne, Inc. (CLRO:NASDAQ), 52.05%
- Smart for Life Inc. (SMFL:NASDAQ), 45.45%
- Jinxin Technology Holding Company (NAMI:NASDAQ), 25.29%
- Future FinTech Group Inc. (FTFT:NASDAQ), 24.75%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 24.28%
- MarketWise Inc. (MKTW:NASDAQ), 23.95%